Skip to main content

How it works Features Calculator Library Compare Pricing

A calm place to organize an existing plan and understand the records around it.

Learn

How it works
Features
Library
Compare
FAQ
Evidence standards

Product

Calculator
Pricing
Install the PWA
Help
Changelog

Trust

Calculation methodology
Safety methodology
Editorial standards
Privacy
Consumer health data
Medical disclaimer
Terms

© 2026 PeptideGridEducational and organizational tools; not medical advice.

Mitochondrial, neurological, and sleep research profiles · PeptideGrid

LibraryMitochondrial, neurological, and sleep research

Mitochondrial, neurological, and sleep research

Research compounds discussed in mitochondrial, neurological, sleep, or ageing-related contexts. The topic is a research grouping, not a health outcome claim.

This is a discovery grouping, not a treatment category. Open a profile to see the exact evidence, risks, forms, routes, and U.S. status.

Published profiles · U.S. context · no rankings.

Search the Library

Save profiles as you explore.

Search names, aliases, product forms, routes, evidence contexts, risks, and uncertainties.

Filters

Refine published profiles

Filters describe published context; they do not rank suitability.

6 results

TypePeptide medicineResearch nonapeptideResearch peptideResearch tetrapeptide

U.S. statusFDA-approved product for specific usesFDA-approved for a different useApproved medicine used outside its labelBeing studied; not FDA-approvedNo FDA-approved product identifiedCosmetic ingredient; not a medicine

Evidence signalMore extensive human evidenceHuman evidenceLimited human evidenceMostly preclinical evidenceClinical evidence not established

RouteIntravenousNasalSubcutaneous

Sort

6 published profiles

Mitochondrial, neurological, and sleep research · Peptide medicineElamipretide / SS-31elamipretideLimited human evidenceFDA-approved product for specific usesSubcutaneous
Mitochondrial, neurological, and sleep research · Research nonapeptideEmideltide (DSIP)delta sleep-inducing peptideLimited human evidenceNo FDA-approved product identifiedIntravenous
Mitochondrial, neurological, and sleep research · Research tetrapeptideEpitalonAEDG peptideMostly preclinical evidenceNo FDA-approved product identifiedRoute in profile
Mitochondrial, neurological, and sleep research · Research peptideMOTS-cmitochondrial open reading frame of the 12S rRNA-cMostly preclinical evidenceNo FDA-approved product identifiedRoute in profile
Mitochondrial, neurological, and sleep research · Research peptideSelankSelancLimited human evidenceNo FDA-approved product identifiedNasal
Mitochondrial, neurological, and sleep research · Research peptideSemaxACTH(4-7)-Pro-Gly-ProLimited human evidenceNo FDA-approved product identifiedNasal

Peptide medicine

Elamipretide / SS-31

Also known as elamipretide, Forzinity

A mitochondria-targeting peptide and active ingredient in Forzinity, an FDA-approved product for a narrow Barth syndrome population.

Evidence signal: Limited human evidence
Forms and routes: Forzinity injection · Subcutaneous
U.S. status: FDA-approved product for specific uses

Open full profile